La Puente, CA, United States of America

Jeremiah H Nguyen

USPTO Granted Patents = 27 

 

 

Average Co-Inventor Count = 2.5

ph-index = 3

Forward Citations = 91(Granted Patents)


Company Filing History:


Years Active: 2006-2021

Loading Chart...
Loading Chart...
Loading Chart...
27 patents (USPTO):Explore Patents

Title: Jeremiah H Nguyen: A Prolific Innovator in Pharmaceutical Patents

Introduction

Jeremiah H Nguyen, based in La Puente, California, is a distinguished inventor recognized for his contributions to the pharmaceutical industry with a remarkable portfolio of 27 patents. His work, particularly in the realm of therapeutic compounds, has made significant strides in the treatment of various inflammatory and autoimmune diseases.

Latest Patents

Nguyen's latest innovations include two noteworthy patents:

1. **3,4-disubstituted 3-cyclobutene-1,2-diones and use thereof** - This patent describes compounds, or pharmaceutically acceptable salts, effective for treating inflammatory and autoimmune diseases.

2. **Substituted arylcyclopentenes as therapeutic agents** - This patent discloses compounds and outlines therapeutic methods, compositions, and medicaments related to them.

Career Highlights

Throughout his career, Jeremiah H Nguyen has been associated with leading pharmaceutical companies, including Allergan, Inc. His work has been pivotal in advancing the field of therapeutics and enhancing the efficacy of treatments available for complex medical conditions.

Collaborations

Nguyen has collaborated with notable professionals in his field, including Yariv Donde and Robert M Burk. These collaborations have underscored his commitment to innovation and have contributed to the successful development of new therapeutic agents.

Conclusion

Jeremiah H Nguyen’s profound impact on the pharmaceutical landscape is evident through his numerous patents and collaborative efforts. His ongoing work continues to open new avenues for treatment and underscores the importance of innovation in addressing pressing health challenges.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…